The effect of sleep on conscious sedation: a follow-up study

B J Sanders1, D R Avery

  • 1Department of Oral Facial Development, Indianapolis, Indiana 46202-5186, USA.

Insights

Preoperative sleep duration did not significantly impact pediatric conscious sedation success. However, parental perception of tiredness showed borderline significance, and older children (over 36 months) had more successful sedations.

Area of Science:

  • Pediatric Anesthesiology
  • Sedation Management
  • Sleep Science

Background:

  • Conscious sedation is frequently used in pediatric dentistry and medicine.
  • Optimizing sedation success is crucial for patient cooperation and procedure efficiency.
  • The role of preoperative sleep in sedation outcomes requires further investigation.

Purpose of the Study:

  • To evaluate the impact of preoperative sleep duration on the success of conscious sedation in children.
  • To explore the correlation between parental perception of child tiredness and sedation outcomes.
  • To identify age-related factors influencing sedation success in pediatric patients.

Main Methods:

  • Seventy-six children (18-61 months) received conscious sedation.
  • Medications included chloral hydrate/hydroxyzine or meperidine hydrochloride.
  • Parental questionnaires assessed preoperative sleep and activity; operators ranked sedation success (1-4 scale).

Main Results:

  • No significant difference in sedation success based on normal or greater preoperative sleep (p < 0.26).
  • Parental perception of child tiredness approached statistical significance (p < 0.08).
  • Children older than 36 months demonstrated significantly higher sedation success rates (p < 0.03).

Conclusions:

  • Preoperative sleep duration does not appear to be a primary determinant of conscious sedation success in young children.
  • A child's perceived tiredness may be a borderline indicator of potential sedation challenges.
  • Increasing age is associated with improved outcomes in pediatric conscious sedation.

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...